Advertisement

Clinical and Prognostic Significance of Molecular Studies in Cutaneous T-Cell Lymphoma

  • S. Whittaker
Part of the Current Topics in Pathology book series (CT PATHOLOGY, volume 94)

Abstract

Mycosis fungoides is the most common form of primary cutaneous T-cell lymphoma (CTCL) and is typically characterised by four cutaneous stages of disease, as described by Bunn and Lamberg [1–3]. In early stages of mycosis fungoides the histological diagnosis can be difficult, and although immunophenotypic studies have helped to distinguish rarer subtypes of primary cutaneous T-cell lymphoma from mycosis fungoides [4], such approaches have not helped in the diagnosis of early-stage disease. While patients with early patch- and plaque-stage disease may have a normal life expectancy, some patients develop tumours or progress to the erythrodermic stages of the disease. Such patients have a median survival of 5 years; the presence of peripheral blood or partial/total lymph node effacement is associated with a poorer prognosis and a median survival of 2.5 years [5]. Significant visceral involvement is usually apparent only in patients who have fulminant disease. Sézary syndrome is characterised by erythroderma, peripheral lymphadenopathy associated with intense pruritus, and the presence of characteristic Sézary cells within peripheral blood. Although most patients with Sézary syndrome have a history of an “eczematous eruption” prior to a diagnosis of cutaneous T-cell lymphoma, some patients with mycosis fungoides gradually develop erythroderma and clinical features indistinguishable from Sézary syndrome. Other independent prognostic factors in mycosis fungoides include age (> 60 years) at presentation, which presumably reflects a poorer host immune response in the elderly [6].

Keywords

Mycosis Fungoides Sezary Syndrome Clonal Rearrangement Granulomatous Slack Skin Sezary Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bunn P, Lamberg S (1979) Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:725–728PubMedGoogle Scholar
  2. 2.
    Bunn P, Huberman M, Whang Peng J, et al. (1980) Prospective staging evaluation of patients with cutaneous T-cell lymphoma. Ann Intern Med 93:223–230PubMedGoogle Scholar
  3. 3.
    Lamberg S, Green S, Byar D, et al. (1984) Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med 100:187–192PubMedGoogle Scholar
  4. 4.
    Willemze R, Kerl H, Sterry W, et al. (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for research and treatment of cancer. Blood 90:354–371PubMedGoogle Scholar
  5. 5.
    Sausville E, Eddy J, Makuch R, et al. (1988) Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups. Am Intern Med 109:372–382Google Scholar
  6. 6.
    Diamandidou E, Colome M, Fayad L, et al. (1999) Prognostic factor analysis in mycosis fungoides/Sézary syndrome. J Am Acad Dermatol 40:914–924PubMedCrossRefGoogle Scholar
  7. 7.
    Schechter G, Sausville E, Fischmann A, et al. (1987) Evaluation of circulating malignant cells provides prognostic information in cutaneous T cell lymphoma. Blood 69:841–849PubMedGoogle Scholar
  8. 8.
    Wasik M, Vonderheid E, Bigler R, et al. (1996) Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma: clinical and prognostic implications. Arch Dermatol 132:42–47PubMedCrossRefGoogle Scholar
  9. 9.
    Marti R, Estrach T, Reverter J, et al. (1991) Prognostic clinicopathologic factors in cutaneous T-cell lymphoma. Arch Dermatol 127:1511–1516PubMedCrossRefGoogle Scholar
  10. 10.
    Alt F, Oltz E, Young F, et al. (1992) VDJ recombination. Immunol Today 13:306–314PubMedCrossRefGoogle Scholar
  11. 11.
    Asou N, Hattori T, Matsuoka M, et al. (1989) Rearrangements of T-cell antigen receptor and immunoglobulin chain gene in haematologic neoplasms. Blood 74:2707–2712PubMedGoogle Scholar
  12. 12.
    Arnold A, Cossman J, Bakhshi A, et al. (1983) Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med 309:1593–1599PubMedCrossRefGoogle Scholar
  13. 13.
    Waldmann T, Davis M, Bongiovanni K et al. (1985) Rearrangements of genes for the antigen receptor on T-cells as markers of lineage and clonality of human lymphoid neoplasms. N Engl J Med 313:776–783PubMedCrossRefGoogle Scholar
  14. 14.
    Bertness V, Kirsch I, Hollis G, et al. (1985) T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med 313:534–538PubMedCrossRefGoogle Scholar
  15. 15.
    McCarthy K, Sloane J, Kabarowski J, et al. (1991) The rapid detection of clonal T-cell proliferations in patients with lymphoid disorders. Am J Pathol 138:821–828PubMedGoogle Scholar
  16. 16.
    McCarthy K, Sloane J, Wiedemann L, et al. (1990) Rapid method for distinguishing clonal from polyclonal B cell populations in surgical biopsy specimens. J Clin Pathol 43:429–432PubMedCrossRefGoogle Scholar
  17. 17.
    Weiss L, Wood G, Trela M, et al. (1986) Clonal T-cell populations in lymphomatoid papulosis. N Engl J Med 315:475–479PubMedCrossRefGoogle Scholar
  18. 18.
    Whittaker S, Smith N, Russell-Jones R, et al. (1991) Analysis of bb, gg and dd T-cell receptor genes in lymphomatoid papulosis: cellular basis of two distinct histologic subsets. J Invest Dermatol 96:786–791PubMedCrossRefGoogle Scholar
  19. 19.
    Headington J, Roth M, Ginsberg D, et al. (1987) T-cell receptor gene rearrangement in regressing atypical histiocytosis. Arch Dermatol 123:1183–1187PubMedCrossRefGoogle Scholar
  20. 20.
    Wood G, Weiss L, Hu C, et al. (1988) T-cell antigen deficiencies and clonal rearrangements of T-cell receptor genes in pagetoid reticulosis (Woringer-Kolopp disease). N Engl J Med 318:164–167PubMedCrossRefGoogle Scholar
  21. 21.
    LeBoit P, Becksteid J, Bond B, et al. (1987) Granulomatous slack skin: clonal rearrangement of the T-cell receptor β gene is evidence for the lymphoproliferative nature of a cutaneous elastolytic disorder. J Invest Dermatol 89:183–186PubMedCrossRefGoogle Scholar
  22. 22.
    LeBoit P, Abel A, Cleary M, et al. (1988) Clonal circulating T-cells in erythrodermic follicular mucinosis. Blood 71:1329–33PubMedGoogle Scholar
  23. 23.
    Weiss L, Hu E, Wood G et al. (1985b) Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med 313:539–544CrossRefGoogle Scholar
  24. 24.
    Whittaker S, Smith N, Russell-Jones R, et al. (1991) Analysis of β, γ and δ T-cell receptor genes in mycosis fungoides and Sézary syndrome. Cancer 68:1572–1582PubMedCrossRefGoogle Scholar
  25. 25.
    Lynch J, Linoilla I, Sausville E, et al. (1992) Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides. Blood 79:3293–3299PubMedGoogle Scholar
  26. 26.
    Bakels V, Van Oostveen J, Geerts S, et al. (1993) Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides. J Pathol 170:249–255PubMedCrossRefGoogle Scholar
  27. 27.
    Weiss L, Wood G, Hu C, et al. (1989) Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sézary syndrome. J Invest Dermatol 92:601–604PubMedCrossRefGoogle Scholar
  28. 28.
    Bagot M, Wechsler J, Lescs M, et al. (1992) Intra-epidermal localisation of the clone in cutaneous T-cell lymphoma. J Am Acad Dermatol 27:589–593PubMedCrossRefGoogle Scholar
  29. 29.
    Bahler D, Berry G, Oksenberg J, et al. (1992) Diversity of T-cell antigen receptor variable genes used by mycosis fungoides cells. Am J Pathol 140:1–8PubMedGoogle Scholar
  30. 30.
    Bogen S, Pelley D, Charif M, et al. (1996) Immunophenotypic identification of Sézary cells in peripheral blood. Am J Clin Pathol 106:739–748PubMedGoogle Scholar
  31. 31.
    Bernengo M, Quaglino P, Novelli M, et al. (1998) Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. Ann Oncol 9:857–863PubMedCrossRefGoogle Scholar
  32. 32.
    Theodorou I, Raphaël M, Bigorgne C, et al. (1994) Recombination pattern of the TCR y locus in human peripheral T-cell lymphomas. J Pathol 174:233–242PubMedCrossRefGoogle Scholar
  33. 33.
    Wood G, Tung R, Haeffner A, et al. (1994) Detection of clonal T-cell receptor y gene rearrangements in early mycosis fungoides/Sézary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 103:34–41PubMedCrossRefGoogle Scholar
  34. 34.
    Muche J, Lukowsky A, Asadullah K, et al. (1997) Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma. Blood 90:1636–1642PubMedGoogle Scholar
  35. 35.
    Fraser-Andrews E, Woolford A, Russell-Jones R, et al. (2000) Detection of a peripheral blood T-cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 114:117–121PubMedCrossRefGoogle Scholar
  36. 36.
    Bottaro M, Berti E, Biondi A, et al. (1994) Heteroduplex analysis of T-cell receptor y gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood 83:3271–3278PubMedGoogle Scholar
  37. 37.
    Davis T, Yockey C, Balk S (1993) Detection of clonal immunoglobulin gene rearrangements by polymerase chain reaction amplification and single strand conformational polymorphism analysis. Am J Pathol 142:1841–1847PubMedGoogle Scholar
  38. 38.
    Boehncke W, Krettek S, Parwaresch M, et al. (1992) Demonstration of clonal disease in early mycosis fungoides. Am J Dermatopathol 14:95–9PubMedCrossRefGoogle Scholar
  39. 39.
    Ling F, Clark C, Lillicrap D (1992) Positive immunoglobulin gene rearrangement study by the polymerase chain reaction in a colonic adenocarcinoma. Am J Patho198:116–119Google Scholar
  40. 40.
    Kern D, Kidd P, Moe R, et al. (1998) Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Arch Dermatol 134:158–164PubMedCrossRefGoogle Scholar
  41. 41.
    Lynch J jr, Linoilla I, Sausville E, et al. (1992) Prognostic implications of evaluation of lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides. Blood 79:3293–3299PubMedGoogle Scholar
  42. 42.
    Posnett D, Sinha R, Kabak S, et al. (1994) Clonal populations of T-cells in normal elderly humans: the T-cell equivalent to “Benign monoclonal gammapathy”. J Exp Med 179:609–618PubMedCrossRefGoogle Scholar
  43. 43.
    Limon J, Nedosztko B, Brozek I, et al. (1995) Chromosome aberrations, spontaneous SCE and growth kinetics in PHA-stimulated lymphocytes in 5 cases of Sézary syndrome. Cancer Genet Cytogenet 83:75PubMedCrossRefGoogle Scholar
  44. 44.
    Thangavelu M, Finn W, Yelavarthi K, et al. (1997) Recurring structural chromosomal abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood 89:3371PubMedGoogle Scholar
  45. 45.
    Babbitts T (1991) Translocations, master genes, and differences between the origins of acute and chronic leukaemias. Cell 67:641–644CrossRefGoogle Scholar
  46. 46.
    Berger R, Bernheim A (1987) Cytogenetic studies of Sézary cells. Cancer Genet Cytogenet 27:79–87PubMedCrossRefGoogle Scholar
  47. 47.
    Karenko L, Hyytinen E, Sarna S, et al. (1997) Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol 108–122Google Scholar
  48. 48.
    Karenko L, Kahkonen M, Hyytinen E, et al. (1999) Notable losses at specific regions of chromosome 10q and 13q in the Sézary syndrome detected by comparative genomic hybridisation. J Invest Dermatol 112–392Google Scholar
  49. 49.
    Galdano G, Ballerini P, Gong J, et al. (1991) p53 Mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukaemia. Proc Natl Acad Sci USA 88:5413–5417CrossRefGoogle Scholar
  50. 50.
    Wilson W, Teruya-Feldstein J, Fest T, et al. (1997) Relationship of p53, bcl-2, and tumour proliferation to clinical drug resistance in non-Hodgkin’s lymphomas. Blood 89:601–609PubMedGoogle Scholar
  51. 51.
    Lauritzen A, Vejlsgaard G, Hou-Jensen K, et al. (1995) p53 protein expression in cutaneous T-cell lymphomas. Br J Dermatol 133:32–36PubMedCrossRefGoogle Scholar
  52. 52.
    McGregor J, Dublin E, Levison D, et al. (1995) p53 immunoreactivity is uncommon in primary cutaneous lymphoma. Br J Dermatol 132:353PubMedCrossRefGoogle Scholar
  53. 53.
    Marks D, Vonderheid E, Kurz B, et al. (1996) Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome. Br J Haematol 92:890–899PubMedCrossRefGoogle Scholar
  54. 54.
    McGregor J, Crook T, Fraser-Andrews E, et al. (1999) Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 112:317–321PubMedCrossRefGoogle Scholar
  55. 55.
    Nataraj A, Wolf P, Cerroni L, et al. (1997) p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA). J Invest Dermatol 109:238–243PubMedCrossRefGoogle Scholar
  56. 56.
    Cartwright R, McNally R, Staines A (1994) The increasing incidence of non-Hodgkin’s lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma 14:387–394PubMedCrossRefGoogle Scholar
  57. 57.
    Newton R (1997) Solar ultraviolet radiation is not a major cause of primary cutaneous non-Hodgkin’s lymphomas. Br Med J 314:1483–1484Google Scholar
  58. 58.
    Lane D (1992) Cancer. P53, guardian of the genome. Nature 358:15–16PubMedCrossRefGoogle Scholar
  59. 59.
    Jones P, Laird P (1999) Cancer epigenetics comes of age. Nat Genet 21:163–167PubMedCrossRefGoogle Scholar
  60. 60.
    Scarisbrick J, Woolford A, Russell-Jones R, et al. (2000) Loss of heterozygosity on l0q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 95:2937–2942PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • S. Whittaker

There are no affiliations available

Personalised recommendations